HCA Competitors

Stocks . UK . 
Stock . HCA Healthcare
0J1R Stock   320.44  6.09  1.94%   
HCA Healthcare competes with American Homes, Clean Power, Ecofin Global, Roebuck Food, and Edita Food; as well as few others. The company operates under Commercial Services & Supplies sector and is part of Industrials industry. Analyzing HCA Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of HCA Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out HCA Healthcare Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of HCA Healthcare competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
319.03321.08323.13
Details
Intrinsic
Valuation
LowRealHigh
265.42267.47352.48
Details
Naive
Forecast
LowNextHigh
321.68323.73325.78
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
298.35316.08333.82
Details

HCA Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between HCA Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of HCA and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of HCA Healthcare does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ABF
+ 0.72
HFG
0IRN
+ 0.63
EGL
HFG
+ 0.62
CPH2
0IRN
+ 0.59
RFG
ABF
+ 0.48
CPH2
EFID
+ 0.42
RFG
  
High negative correlations   
ABF
- 0.64
0IRN
0IRN
- 0.63
0HEJ
ABF
- 0.58
EGL
EGL
- 0.32
0HEJ
HFG
- 0.3
EGL
HFG
- 0.28
0IRN

Risk-Adjusted Indicators

There is a big difference between HCA Stock performing well and HCA Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HCA Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

HCA Healthcare Competitive Analysis

The better you understand HCA Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, HCA Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across HCA Healthcare's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
0J1R 0HEJ CPH2 EGL RFG EFID 0IRN HFG ABF
 1.94 
 320.44 
HCA
 0.71 
 34.85 
American
 4.35 
 6.60 
Clean
 1.08 
 187.00 
Ecofin
 0.00 
 16.50 
Roebuck
 0.51 
 1.99 
Edita
 1.24 
 59.95 
Fortune
 1.58 
 834.00 
Hilton
 0.62 
 1,853 
Associated
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Somewhat reliable
Very steady
Very steady
Moderately volatile
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weak
Very Weak
Very Weak
OK
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Very Small
Very Small
Low
Below Average
Low
Very Small
Low
Very Small
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Buy
Hold
Strong Sell
Cautious Hold
Strong Sell
Hold
Strong Sell
Cautious Hold
Net Asset
59.51 B
12.69 B
24.51 M
278.82 M
12.51 M
7.74 B
7.94 B
1.29 B
19.01 B
Profit Margin
0.0816
0.24
N/A
N/A
-0.17
N/A
0.1
0.0122
0.0725
EBITDA
13.86 B
806.26 M
(4.67 M)
(18.65 M)
(1.12 M)
2.33 B
961.1 M
163.59 M
3.13 B
Operating Margin
0.16
0.24
N/A
0.93
-0.0479
N/A
0.18
0.0225
0.0995
Current Valuation
125.85 B
18.47 B
20.23 M
218.86 M
16.83 M
N/A
9.96 B
1.1 B
15.4 B
Price To Book
N/A
N/A
1.26
0.81
7.4
N/A
N/A
2.47
1.2
Retained Earnings
(2.12 B)
(394.91 M)
(13.13 M)
N/A
3.35 M
3.32 B
2.32 B
175.96 M
11.39 B
Beta
1.69
0.78
0.21
0.54
0.1
N/A
1.6
0.53
1.2
Number Of Employees
226 K
1.73 K
55
N/A
16
6.02 K
11 K
7 K
138 K
Shares Outstanding
344.16 M
299.08 M
354.42 M
110.63 M
101.14 M
N/A
141.4 M
89.83 M
721.76 M
Cash Flow From Operations
10.51 B
738.69 M
(2.35 M)
5.64 M
1.75 M
1.07 B
566.3 M
166.93 M
2.91 B
Annual Yield
N/A
1.0E-4
N/A
0.0465
N/A
N/A
N/A
0.0391
0.034
Total Debt
45.24 B
4.48 B
737 K
35.59 M
1.14 M
2.17 B
2.31 B
493.29 M
3.68 B
Return On Equity
0.82
0.0604
-0.23
-0.044
-0.5
N/A
0.2
0.16
0.13
Return On Asset
0.11
0.0192
-0.15
-0.0197
-0.071
N/A
0.0731
0.0536
0.063
Book Value Per Share
-10.0
19.37
0.069
1.96
0.045
N/A
19.59
3.38
15.12
Total Asset
59.51 B
12.69 B
24.51 M
278.82 M
12.51 M
7.74 B
7.94 B
1.29 B
19.01 B
Last Dividend Paid
2.64
1.04
N/A
0.082
N/A
0.03
0.96
0.33
0.63
Target Price
N/A
N/A
68.0
N/A
N/A
N/A
N/A
1081.43
2249.11
Shares Owned By Institutions
65.34
89.95
3.59
44.02
6.54
N/A
98.63
64.74
17.68
Market Capitalization
112.73 B
1.24 T
23.39 M
199.97 M
16.69 M
N/A
847.96 B
749.16 M
13.37 B
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.12
Price To Sales
1.56
7.18
1869.35
3.97
0.54
N/A
1.84
0.2
0.67
Net Income
5.76 B
380.17 M
(4.12 M)
52.98 M
(1.85 M)
1.63 B
404.5 M
36.38 M
1.46 B
Earnings Per Share
21.29
0.48
-0.02
-0.09
-0.06
N/A
5.62
0.51
1.94
Shares Owned By Insiders
28.99
7.74
51.2
0.75
15.54
N/A
0.48
14.24
59.2
Revenue
70.6 B
1.62 B
N/A
52.57 M
26.74 M
12.13 B
4.61 B
3.99 B
20.07 B
Working Capital
N/A
N/A
11.91 M
N/A
815 K
1.22 B
N/A
84.18 M
N/A
Gross Profit
28.68 B
961.3 M
3 K
25.96 M
183 K
N/A
2.09 B
425.2 M
1.84 B
Day Typical Price
318.23
34.93
6.57
186.17
16.67
1.99
60.2
830.63
1848.33
Accumulation Distribution
0.0257
0.0071
0.0152
0.0239
0.0294
0.005
0.0124
0.0192
0.014
Market Facilitation Index
8.27
0.25
0.1
4.5
0.5
0.01
0.75
16.11
26.0
Daily Balance Of Power
0.7364
(1.00)
(3.00)
0.4444
N/A
1.0
(1.00)
0.807
0.4423
Period Momentum Indicator
6.09
(0.25)
(0.30)
2.0
N/A
0.01
(0.75)
13.0
11.5
Rate Of Daily Change
1.02
0.99
0.96
1.01
1.0
1.01
0.99
1.02
1.01
Day Median Price
317.13
34.98
6.55
185.75
16.75
1.99
60.33
828.95
1846.0
Price Action Indicator
6.36
(0.25)
(0.10)
2.25
(0.25)
0.01
(0.75)
11.56
12.75
Coefficient Of Variation
3593.12
(1,028)
(748.80)
1029.98
(3,523)
(753,073)
(463.34)
(1,170)
(614.80)
Mean Deviation
1.5
1.07
1.07
0.9213
0.2078
0.2121
1.6
0.9566
1.11
Jensen Alpha
0.0889
(0.11)
(0.20)
0.0954
(0.03)
(0.03)
(0.42)
(0.13)
(0.23)
Total Risk Alpha
0.3044
0.0281
(0.03)
0.27
0.0711
0.1435
(0.21)
0.0401
(0.06)
Sortino Ratio
0.0634
N/A
N/A
0.1858
N/A
N/A
N/A
N/A
N/A
Downside Variance
6.07
N/A
N/A
1.42
N/A
N/A
N/A
N/A
N/A
Standard Deviation
2.05
1.36
1.84
1.26
0.8371
1.23
2.19
1.26
1.44
Kurtosis
1.63
0.3077
6.72
2.69
35.75
32.5
1.25
0.9176
0.1378
Potential Upside
2.95
2.58
3.31
2.18
N/A
N/A
2.87
1.58
2.24
Treynor Ratio
0.1231
(0.51)
(0.52)
(0.73)
(1.19)
0.046
(0.91)
0.9344
(1.98)
Maximum Drawdown
12.44
6.25
12.16
7.98
8.66
7.0
10.44
7.14
7.02
Variance
4.22
1.85
3.39
1.59
0.7008
1.51
4.8
1.58
2.06
Market Risk Adjusted Performance
0.1331
(0.50)
(0.51)
(0.72)
(1.18)
0.056
(0.90)
0.9444
(1.97)
Risk Adjusted Performance
0.03
(0.08)
(0.11)
0.0876
(0.03)
0.0028
(0.18)
(0.07)
(0.14)
Skewness
(0.49)
0.2111
0.7223
0.6402
(4.22)
(0.01)
(0.74)
0.3795
(0.32)
Semi Deviation
2.31
N/A
N/A
0.942
N/A
N/A
N/A
N/A
N/A
Information Ratio
0.076
(0.02)
(0.08)
0.1757
0.0899
0.0806
(0.17)
(0.01)
(0.09)
Value At Risk
(3.22)
(2.65)
(3.38)
(1.32)
N/A
N/A
(4.51)
(1.95)
(2.81)
Expected Short fall
(1.35)
N/A
N/A
(1.20)
N/A
N/A
N/A
N/A
N/A
Downside Deviation
2.46
N/A
N/A
1.19
N/A
N/A
N/A
N/A
N/A
Semi Variance
5.34
N/A
N/A
0.8874
N/A
N/A
N/A
N/A
N/A

HCA Healthcare Competition Performance Charts

Five steps to successful analysis of HCA Healthcare Competition

HCA Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by HCA Healthcare in relation to its competition. HCA Healthcare's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of HCA Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact HCA Healthcare's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to HCA Healthcare, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your HCA Healthcare position

In addition to having HCA Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Warren Buffett Holdings Thematic Idea Now

Warren Buffett Holdings
Warren Buffett Holdings Theme
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for HCA Stock Analysis

When running HCA Healthcare's price analysis, check to measure HCA Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HCA Healthcare is operating at the current time. Most of HCA Healthcare's value examination focuses on studying past and present price action to predict the probability of HCA Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HCA Healthcare's price. Additionally, you may evaluate how the addition of HCA Healthcare to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY